Omada Health (OMDA) closed at $15.09 on November 6, 2026, down 20.4% from the previous close, on volume of 4,490,082 shares (30-day average 1,088,524).
Data as of November 6, 2026.
6-Nov-2026
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Nov 6, 2026 | Call Spread | 15-Jan-2715 : 17.5 C | 9,786 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 6, 2026. See the 10 largest for 30, 60 and 90 days
Omada Health Earnings Call Signals Strong Growth Ahead
TipRanks (Fri, 6-Nov 7:10 PM ET)
Omada’s Strong Q3 Execution and Growth Drivers Support Buy Rating; $30 Price Target Unchanged
TipRanks (Fri, 6-Nov 2:36 PM ET)
Wall Street Analysts Are Neutral on Top NA Picks
TipRanks (Fri, 6-Nov 9:21 AM ET)
Omada Health’s Strong Q3 Execution and Raised Outlook Support Buy Rating; $35 Price Target Unchanged
TipRanks (Fri, 6-Nov 9:05 AM ET)
TipRanks (Fri, 6-Nov 4:03 AM ET)
Omada Health, Inc. GAAP EPS of $0.10 beats by $0.07, revenue of $91M beats by $5.36M
Seeking Alpha News (Thu, 5-Nov 4:17 PM ET)
Omada Health Reports Third Quarter 2026 Results
Globe Newswire (Thu, 5-Nov 4:02 PM ET)
Globe Newswire (Thu, 22-Oct 12:17 PM ET)
Globe Newswire (Tue, 20-Oct 9:00 AM ET)
Omada Health Sets Nov. 5 Q3 2026 Earnings Call as It Highlights a 2M+ Member Virtual-First Model
Market Chameleon (Tue, 13-Oct 7:04 AM ET)
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
Omada Health trades on the NASDAQ stock market under the symbol OMDA.
As of November 6, 2026, OMDA stock price declined to $15.09 with 4,490,082 million shares trading.
OMDA has a beta of 2.31, meaning it tends to be more sensitive to market movements. OMDA has a correlation of 0.15 to the broad based SPY ETF.
OMDA has a market cap of $923.76 million. This is considered a Small Cap stock.
Last quarter Omada Health reported $91 million in Revenue and $.10 earnings per share. This beat revenue expectation by $5 million and exceeded earnings estimates by $.02.
The top ETF exchange traded funds that OMDA belongs to (by Net Assets): VTI, IWM, VXF, IWO, FYC.
OMDA has underperformed the market in the last year with a price return of -31.0% while the SPY ETF gained +10.8%. OMDA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.8% and -20.4%, respectively, while the SPY returned -4.1% and -3.2%, respectively.
OMDA support price is $18.19 and resistance is $19.71 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OMDA shares will trade within this expected range on the day.
